SCHEMBL4563202

SCHEMBL4563202

c1ccc(C(=NNc2ccc3ccccc3n2)c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.55
RAB9A P51151 9/20 0.55
SMN1; SMN2 Q16637 8/20 0.55
CCR6 P51684 2/20 0.55
TP53 P04637 2/20 0.55
CXCR5 P32302 1/20 0.55
APLNR P35414 1/20 0.55
LRRK2 Q5S007 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
PAX8 Q06710 2/20 0.54
NCF1 P14598 1/20 0.50
HTT P42858 4/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
KMT2A Q03164 6/20 0.46
MAPT P10636 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4916024 0.86 PAX8 (0.68) NPC1RAB9ASMN1; SMN2CCR6TP53
SCHEMBL12706320 0.86 PAX8 (0.68) NPC1RAB9ASMN1; SMN2CCR6TP53
SCHEMBL20101097 0.84 CCR6 (0.68) NPC1RAB9ASMN1; SMN2CCR6TP53
SCHEMBL11332741 0.78 RAB9A (0.49) NPC1RAB9ASMN1; SMN2CCR6TP53
SCHEMBL18693004 0.73 ALDH1A1 (0.47) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL28476553 0.71 NPC1 (0.66) NPC1RAB9ASMN1; SMN2NCF1KMT2A
SCHEMBL6257291 0.71 NPC1 (1.00) NPC1RAB9ASMN1; SMN2TP53KMT2A
SCHEMBL14075818 0.71 SMN1; SMN2 (1.00) NPC1RAB9ASMN1; SMN2CCR6TP53
SCHEMBL15267189 0.70 KDM4E (0.58) NPC1RAB9ASMN1; SMN2TP53CYP1A2
SCHEMBL1133878 0.70 NCF1 (0.65) NPC1RAB9ASMN1; SMN2CCR6TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2073811-A2 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES Deciphera Pharmaceuticals, LLC. (US) 2009-07-01 EP disclosed
WO-2008046003-A2 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES DECIPHERA PHARMACEUTICALS, LLC (US) 2008-04-17 WO disclosed